In this episode, I had the pleasure of interviewing Dr Peeter Padrik, CEO and founder of Estonian healthcare startup Antegenes. Antegenes has developed innovative genetic tests for cancer prevention, based on polygenic risk score technology. The company has done over 16,000 tests in Estonia and in the UK and is now expanding into new markets such as Germany. Antegenes also started projects to enter public cancer screening in several European countries. The company is currently aiming for a series A financing.